Recently, we and others showed the cooperative oncogenic effect of MYCN and activated ALK in prompting neuroblastomagenesis in both transgenic mouse and zebrafish models of neuroblastoma [36,37,38]; our results further confirm ALK is a key oncogenic driver, in collaboration with MYCN, in neuroblastoma pathogenesis. The gene discussed is MYCN; the disease is neuroblastoma.